Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perception and tolerability of nicotine oral films in healthy smokers
2004-004575-11Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nicotine in nicotine dependence (2 arms), sponsored by Pfizer. Primary endpoint: Overall acceptability at 20 minutes after dose. Started Dec 2004; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2004-004575-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004575-11.